Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 3
1997 3
1999 6
2000 2
2001 3
2002 1
2003 8
2004 2
2005 2
2007 2
2008 2
2009 1
2010 2
2011 1
2013 3
2014 1
2015 4
2016 2
2017 2
2018 1
2019 1
2020 5
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

57 results
Results by year
Filters applied: . Clear all
Page 1
SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations.
Pudelko L, Jaehrling F, Reusch C, Vitri S, Stroh C, Linde N, Sanderson MP, Musch D, Lebrun CJ, Keil M, Esdar C, Blaukat A, Rosell R, Schumacher KM, Karachaliou N. Pudelko L, et al. Among authors: blaukat a. iScience. 2020 Nov 20;23(12):101832. doi: 10.1016/j.isci.2020.101832. eCollection 2020 Dec 18. iScience. 2020. PMID: 33305187 Free PMC article.
Allosteric IGF-1R Inhibitors.
Heinrich T, Grädler U, Böttcher H, Blaukat A, Shutes A. Heinrich T, et al. Among authors: blaukat a. ACS Med Chem Lett. 2010 May 18;1(5):199-203. doi: 10.1021/ml100044h. eCollection 2010 Aug 12. ACS Med Chem Lett. 2010. PMID: 24900194 Free PMC article.
57 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page